Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Moodys
Mallinckrodt
Baxter
AstraZeneca

Last Updated: February 7, 2023

CLINICAL TRIALS PROFILE FOR SARAFEM


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Sarafem

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00339079 ↗ Treatment of Hypochondriasis With CBT and/or SSRI Completed National Institute of Mental Health (NIMH) Phase 1/Phase 2 2006-06-01 This study will compare the effectiveness of cognitive behavioral therapy, antidepressant medication, and a combination of the two for treating hypochondriasis.
NCT00339079 ↗ Treatment of Hypochondriasis With CBT and/or SSRI Completed Brigham and Women's Hospital Phase 1/Phase 2 2006-06-01 This study will compare the effectiveness of cognitive behavioral therapy, antidepressant medication, and a combination of the two for treating hypochondriasis.
NCT00678574 ↗ The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder Completed National Institute of Mental Health (NIMH) Phase 4 1998-03-01 The purpose of the study proposed is to investigate the role of neurosteroids and GABA in the pathophysiology and treatment of premenstrual dysphoric disorder (PMDD) by 1) measuring cortical gama-aminobutyric acid levels (GABA levels) using nuclear magnetic resonance spectroscopy (MRS) during the follicular and mid-luteal phases of the menstrual cycle pre and post treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac®, Sarafem®), and 2) correlating cerebrospinal fluid (CSF) and plasma GABA and neurosteroid levels with cortical GABA levels at these same time points. Neurosteroids to be measured include allopregnanolone, pregnenolone, and pregnenolone sulfate. Findings from women with PMDD will be compared to those of healthy subjects.
NCT00678574 ↗ The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder Completed University of Pennsylvania Phase 4 1998-03-01 The purpose of the study proposed is to investigate the role of neurosteroids and GABA in the pathophysiology and treatment of premenstrual dysphoric disorder (PMDD) by 1) measuring cortical gama-aminobutyric acid levels (GABA levels) using nuclear magnetic resonance spectroscopy (MRS) during the follicular and mid-luteal phases of the menstrual cycle pre and post treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac®, Sarafem®), and 2) correlating cerebrospinal fluid (CSF) and plasma GABA and neurosteroid levels with cortical GABA levels at these same time points. Neurosteroids to be measured include allopregnanolone, pregnenolone, and pregnenolone sulfate. Findings from women with PMDD will be compared to those of healthy subjects.
NCT01174394 ↗ Electroacupuncture Combined With Antidepressants for Post-stroke Depression Completed Kowloon Hospital, Hong Kong N/A 2010-05-01 This is a randomized, assessor-blind, placebo controlled study in post stroke depression patients. Subjects receiving antidepressant drug would be assigned to either active or placebo scalp electro-acupuncture treatment, on the hypothesis that acupuncture intervention combined with antidepressants could produce greater therapeutic effects than antidepressants alone.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sarafem

Condition Name

Condition Name for Sarafem
Intervention Trials
Major Depressive Disorder 4
Depression 2
Healthy Subjects 2
Hypochondriasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sarafem
Intervention Trials
Depressive Disorder 5
Depression 5
Depressive Disorder, Major 4
Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sarafem

Trials by Country

Trials by Country for Sarafem
Location Trials
United States 5
Japan 2
Hong Kong 2
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sarafem
Location Trials
New York 2
Georgia 1
Connecticut 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sarafem

Clinical Trial Phase

Clinical Trial Phase for Sarafem
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sarafem
Clinical Trial Phase Trials
Completed 8
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sarafem

Sponsor Name

Sponsor Name for Sarafem
Sponsor Trials
National Institute of Mental Health (NIMH) 2
Torrent Pharmaceuticals Limited 2
Kowloon Hospital, Hong Kong 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sarafem
Sponsor Trials
Other 11
Industry 4
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
AstraZeneca
Boehringer Ingelheim
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.